These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 4324137

  • 1. [Role of transcutaneous radiotherapy in the treatment of pituitary adenoma].
    Ennuyer A, Bataïni P, Dhermain P, Throuvalas N.
    Bull Cancer; 1969; 56(2):135-68. PubMed ID: 4324137
    [No Abstract] [Full Text] [Related]

  • 2. Heavy-particle therapy for acromegaly, Cushing's disease, Nelson's syndrome, and nonfunctioning pituitary adenomas.
    Linfoot JA, Chong CY, Garcia JF, Cleveland AS, Connell GM, Manougian E, Okerlund MD, Born JL, Lawrence JH.
    Prog At Med; 1971; 3():219-38. PubMed ID: 4335128
    [No Abstract] [Full Text] [Related]

  • 3. [Stereotaxic cryodestruction of hypophyseal tumors].
    Kandel' EI, Atlas DV, Sklianik AIa.
    Vopr Neirokhir; 1973; 37(5):8-14. PubMed ID: 4360230
    [No Abstract] [Full Text] [Related]

  • 4. [Results of primary and combined operative-stereotaxic irradiation of pituitary adenomas].
    Mundinger F.
    Nucl Med (Stuttg); 1965; ():Suppl 2:397+. PubMed ID: 4296219
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The relationship of time-dose fractionation factors to complications in the treatment of pituitary tumors by irradiation.
    Aristizabal S, Caldwell WL, Avila J.
    Int J Radiat Oncol Biol Phys; 1977; 2(7-8):667-73. PubMed ID: 197051
    [No Abstract] [Full Text] [Related]

  • 9. Current treatment of pituitary adenomas: a review.
    Elkon D.
    Va Med; 1980 Sep; 107(9):627-9. PubMed ID: 6259848
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Progress report on the treatment of Cushing's disease.
    Linfoot JA, Lawrence JH, Tobias CA, Born JL, Chong CY, Lyman JT, Manougian E.
    Trans Am Clin Climatol Assoc; 1970 Sep; 81():196-212. PubMed ID: 4330035
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Relationship of time dose factors to tumor control and complications in the treatment of Cushing's disease by irradiation.
    Aristizabal S, Caldwell WL, Avila J, Mayer EG.
    Int J Radiat Oncol Biol Phys; 1977 Sep; 2(1-2):47-54. PubMed ID: 191427
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Hypofunction of peripheral target-gland after radiotherapy of pituitary adenoma--an analysis of 140 cases].
    Cui SX.
    Zhonghua Zhong Liu Za Zhi; 1990 May; 12(3):227-30. PubMed ID: 2174331
    [Abstract] [Full Text] [Related]

  • 19. [The treatment of eosinophilic and chromophobe adenomas of the pituitary gland with radioactive yttrium implants].
    Dogliotti GC, Molinatti GM.
    Minerva Med; 1967 Dec 12; 58(99):4528-9. PubMed ID: 4295508
    [No Abstract] [Full Text] [Related]

  • 20. [Long-term results of radiation therapy for pituitary adenoma--analysis of 386 cases].
    Zhang BX.
    Zhonghua Zhong Liu Za Zhi; 1990 Jan 12; 12(1):63-5. PubMed ID: 2163825
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.